Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Vireo Growth Inc. (VREOF) Form 8-K — Aug 26, 2026

$VREOFForm 8-KItems 2.01, 3.02, 7.01, 9.01Filed Aug 26, 2026, 4:05 PM ET0001104659-26-101481Original filing

Vireo Growth Inc. completed its previously announced acquisition of C21 Investments Inc. on August 21, 2026, through a court-approved plan of arrangement, issuing 2,766,409 subordinate voting shares at an exchange ratio of 0.023052 Vireo shares per C21 share. C21 is now a wholly owned subsidiary, and its shares were delisted from the Canadian Securities Exchange and ceased quoting on the OTCQX Market.

Key figures

Closing date
2026-08-21
Consideration type
all-share, Section 3(a)(10) exemption
Vireo shares issued
2766409
Nevada dispensaries added
3
Vireo states of operation
10
Arrangement agreement date
2026-06-14
C21 shareholder approval date
2026-08-07
Post deal nevada dispensaries
approximately 14
Vireo dispensaries nationwide
approximately 170
Exchange ratio vireo shares per c21 share
0.023052
Cultivation production capacity added sqft
104000
Post deal nevada cultivation manufacturing capacity sqft
159000

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.